Subscribe To
EW / Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Content Topics
Edwards
Lifesciences
Rising
Dominance
In
Structural
Heart
Lifesciences
In structural
Disease
Stock
EW
EW News
By Zacks Investment Research
October 30, 2023
ITGR or EW: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Edwards Lifesciences (EW). But which of the more_horizontal
By The Motley Fool
October 26, 2023
Why Edwards Lifesciences Stock Plummeted Today
The maker of medical devices posted third-quarter results that broadly met analyst expectations. That wasn't the reason for the resulting investor sel more_horizontal
By Zacks Investment Research
October 26, 2023
Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip
Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter more_horizontal
By Seeking Alpha
October 26, 2023
Edwards Lifesciences Corporation (EW) Q3 2023 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW ) Q3 2023 Earnings Conference Call October 25, 2023 5:00 PM ET Company Participants Mark Wilterding - SVP, I more_horizontal
By Zacks Investment Research
October 25, 2023
Edwards Lifesciences (EW) Q3 Earnings Match Estimates
Edwards Lifesciences (EW) came out with quarterly earnings of $0.59 per share, in line with the Zacks Consensus Estimate. This compares to earnings of more_horizontal
By Reuters
October 25, 2023
Edwards Lifesciences quarterly sales jump on robust demand for heart devices
Edwards Lifesciences Corp on Wednesday reported a 12% rise in third-quarter sales, helped by strong demand for the company's artificial heart valves a more_horizontal
By Zacks Investment Research
October 25, 2023
5 Large-Cap Stocks to Buy Ahead of Q3 Earnings This Week
We have narrowed our search to five large-cap stocks that are set to declare third-quarter earnings results this week. These are: EW, VICI, VMC, GLPI, more_horizontal
By Zacks Investment Research
October 23, 2023
What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?
Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN platform. more_horizontal